Home/Filings/3/0000899243-23-016434
3//SEC Filing

Pillar Invest Corp 3

Accession 0000899243-23-016434

CIK 0000861838other

Filed

Jun 22, 8:00 PM ET

Accepted

Jun 23, 7:19 PM ET

Size

17.7 KB

Accession

0000899243-23-016434

Insider Transaction Report

Form 3
Period: 2023-05-16
Holdings
  • Common Stock

    (indirect: By Abude Umari)
    170,712
  • Warrants

    (indirect: By Pillar Pharmaceuticals 6, L.P.)
    Exercise: $0.01From: 2020-12-11Exp: 2023-12-11Common Stock (45,114 underlying)
  • Common Stock

    (indirect: By Foundation)
    355,247
  • Common Stock

    (indirect: By Youssef El Zein)
    1,547
  • Warrants

    (indirect: By Foundation)
    Exercise: $0.01From: 2020-12-11Exp: 2023-12-11Common Stock (35,687 underlying)
  • Warrants

    (indirect: By Foundation)
    Exercise: $0.01From: 2020-07-13Exp: 2023-07-13Common Stock (162,601 underlying)
  • Common Stock

    (indirect: By Pillar Pharmaceuticals 6, L.P)
    135,540
Pillar Invest Corp
Director10% Owner
Holdings
  • Common Stock

    (indirect: By Abude Umari)
    170,712
  • Warrants

    (indirect: By Pillar Pharmaceuticals 6, L.P.)
    Exercise: $0.01From: 2020-12-11Exp: 2023-12-11Common Stock (45,114 underlying)
  • Common Stock

    (indirect: By Youssef El Zein)
    1,547
  • Common Stock

    (indirect: By Foundation)
    355,247
  • Common Stock

    (indirect: By Pillar Pharmaceuticals 6, L.P)
    135,540
  • Warrants

    (indirect: By Foundation)
    Exercise: $0.01From: 2020-07-13Exp: 2023-07-13Common Stock (162,601 underlying)
  • Warrants

    (indirect: By Foundation)
    Exercise: $0.01From: 2020-12-11Exp: 2023-12-11Common Stock (35,687 underlying)
Holdings
  • Common Stock

    (indirect: By Foundation)
    355,247
  • Common Stock

    (indirect: By Pillar Pharmaceuticals 6, L.P)
    135,540
  • Common Stock

    (indirect: By Abude Umari)
    170,712
  • Common Stock

    (indirect: By Youssef El Zein)
    1,547
  • Warrants

    (indirect: By Foundation)
    Exercise: $0.01From: 2020-07-13Exp: 2023-07-13Common Stock (162,601 underlying)
  • Warrants

    (indirect: By Pillar Pharmaceuticals 6, L.P.)
    Exercise: $0.01From: 2020-12-11Exp: 2023-12-11Common Stock (45,114 underlying)
  • Warrants

    (indirect: By Foundation)
    Exercise: $0.01From: 2020-12-11Exp: 2023-12-11Common Stock (35,687 underlying)
Umari Abude
10% Owner
Holdings
  • Warrants

    (indirect: By Foundation)
    Exercise: $0.01From: 2020-07-13Exp: 2023-07-13Common Stock (162,601 underlying)
  • Common Stock

    (indirect: By Youssef El Zein)
    1,547
  • Common Stock

    (indirect: By Abude Umari)
    170,712
  • Warrants

    (indirect: By Pillar Pharmaceuticals 6, L.P.)
    Exercise: $0.01From: 2020-12-11Exp: 2023-12-11Common Stock (45,114 underlying)
  • Common Stock

    (indirect: By Foundation)
    355,247
  • Common Stock

    (indirect: By Pillar Pharmaceuticals 6, L.P)
    135,540
  • Warrants

    (indirect: By Foundation)
    Exercise: $0.01From: 2020-12-11Exp: 2023-12-11Common Stock (35,687 underlying)
Holdings
  • Common Stock

    (indirect: By Foundation)
    355,247
  • Common Stock

    (indirect: By Pillar Pharmaceuticals 6, L.P)
    135,540
  • Common Stock

    (indirect: By Youssef El Zein)
    1,547
  • Warrants

    (indirect: By Foundation)
    Exercise: $0.01From: 2020-12-11Exp: 2023-12-11Common Stock (35,687 underlying)
  • Common Stock

    (indirect: By Abude Umari)
    170,712
  • Warrants

    (indirect: By Foundation)
    Exercise: $0.01From: 2020-07-13Exp: 2023-07-13Common Stock (162,601 underlying)
  • Warrants

    (indirect: By Pillar Pharmaceuticals 6, L.P.)
    Exercise: $0.01From: 2020-12-11Exp: 2023-12-11Common Stock (45,114 underlying)
Footnotes (2)
  • [F1]Pillar Invest Corporation ("Pillar GP") is the general partner of Pillar Pharmaceuticals 6, L.P. ("Pillar 6") and Pillar Partners Foundation, L.P. ("Pillar Partners", together with Pillar GP and Pillar 6, the "Pillar Funds"). Youssef El Zein and Abude Umari are directors of Pillar GP. Each of Pillar GP, Mr. El Zein and Mr. Umari disclaims Section 16 beneficial ownership of the securities beneficially owned by the Pillar Funds and this report shall not be deemed an admission that any of Pillar GP, Mr. El Zein or Mr. Umari is the Section 16 beneficial owner of any such securities, except to the extent of its or his pecuniary interest therein, if any, by virtue of its or his ownership interest in the Pillar Funds or Pillar GP, as applicable.
  • [F2]The warrants are exercisable subject to a beneficial ownership blocker provision that prevents the holder from exercising the warrants if such exercise would result in the holder beneficially owning more than 19.99% of the Issuer's Common Stock outstanding following such exercise.

Issuer

Aceragen, Inc.

CIK 0000861838

Entity typeother
IncorporatedCayman Islands

Related Parties

1
  • filerCIK 0001534428

Filing Metadata

Form type
3
Filed
Jun 22, 8:00 PM ET
Accepted
Jun 23, 7:19 PM ET
Size
17.7 KB